309 related articles for article (PubMed ID: 8717259)
1. [The experimental study of myocardial protection for warm myocardial ischemia in an isolated rat heart: the effect of a calcium antagonist].
Fukuhiro Y
Nihon Kyobu Geka Gakkai Zasshi; 1996 Feb; 44(2):130-7. PubMed ID: 8717259
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart.
Greenfield DT; Greenfield LJ; Hess ML
J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928
[TBL] [Abstract][Full Text] [Related]
3. [Diltiazem abolishes the effect of ryanodine in St. Thomas' Hospital cardioplegic solution on the post-ischemic functional recovery].
Yamamoto H; Ichikawa H; Yamamoto F
Nihon Kyobu Geka Gakkai Zasshi; 1995 Jan; 43(1):19-25. PubMed ID: 7884256
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the protective prorerties of St. Thomas', Tyers', and Bretschneider's cardioplegic solutions in the neonatal rabbit heart].
Murashita T; Yasuda K
Nihon Kyobu Geka Gakkai Zasshi; 1996 Nov; 44(11):2019-26. PubMed ID: 8958717
[TBL] [Abstract][Full Text] [Related]
5. St. Thomas' Hospital cardioplegic solution. Beneficial effect of glucose and multidose reinfusions of cardioplegic solution.
von Oppell UO; Du Toit EF; King LM; Owen P; Dunne T; Reichart B; Opie LH
J Thorac Cardiovasc Surg; 1991 Sep; 102(3):405-12. PubMed ID: 1881179
[TBL] [Abstract][Full Text] [Related]
6. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
[TBL] [Abstract][Full Text] [Related]
7. [Effects of ischemic preconditioning on the recovery of myocardial function after unprotected ischemia and cardioplegia in the isolated and crystalloid perfused rat hearts].
Otani H; Kawasaki H; Ninomiya H; Kido M; Kawaguchi H; Osako M; Kato Y; Imamura H
Nihon Kyobu Geka Gakkai Zasshi; 1997 Jan; 45(1):23-30. PubMed ID: 9028119
[TBL] [Abstract][Full Text] [Related]
8. Superior protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium. Clinical study in comparison with St. Thomas' Hospital solution.
Kinoshita K; Oe M; Tokunaga K
J Thorac Cardiovasc Surg; 1991 Apr; 101(4):695-702. PubMed ID: 2008108
[TBL] [Abstract][Full Text] [Related]
9. Myocardial protection: efficacy of a novel magnesium-based cardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution.
Maruyama Y; Chambers DJ
Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):745-9. PubMed ID: 18550603
[TBL] [Abstract][Full Text] [Related]
10. Improved myocardial protection by oxygenation of St. Thomas' Hospital cardioplegic solutions. Studies in the rat.
Ledingham SJ; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1988 Jan; 95(1):103-11. PubMed ID: 3336223
[TBL] [Abstract][Full Text] [Related]
11. Long-term preservation of the heart: the effect of infusion pressure during continuous hypothermic cardioplegia.
Chambers DJ; Takahashi A; Hearse DJ
J Heart Lung Transplant; 1992; 11(4 Pt 1):665-75. PubMed ID: 1498129
[TBL] [Abstract][Full Text] [Related]
12. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
Kempsford RD; Hearse DJ
J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580
[TBL] [Abstract][Full Text] [Related]
13. Lowering the calcium concentration in St. Thomas' Hospital cardioplegic solution improves protection during hypothermic ischemia.
Robinson LA; Harwood DL
J Thorac Cardiovasc Surg; 1991 Feb; 101(2):314-25. PubMed ID: 1992242
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of University of Wisconsin solution on prolonged myocardial protection as assessed by phosphorus 31-nuclear magnetic resonance spectroscopy and functional recovery.
Karck M; Vivi A; Tassini M; Schwalb H; Askenasy N; Navon G; Borman JB; Uretzky G
J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1356-64. PubMed ID: 1434717
[TBL] [Abstract][Full Text] [Related]
15. Transient hypocalcemic reperfusion does not improve postischemic recovery in the rat heart after preservation with St. Thomas' Hospital cardioplegic solution.
Chambers DJ; Harvey DM; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1992 Aug; 104(2):344-56. PubMed ID: 1495296
[TBL] [Abstract][Full Text] [Related]
16. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium.
Baker JE; Boerboom LE; Olinger GN
J Thorac Cardiovasc Surg; 1988 Nov; 96(5):717-24. PubMed ID: 3184966
[TBL] [Abstract][Full Text] [Related]
17. Protection of the ischemic immature heart--effect of perfusate reinfusion and composition.
Baker JE; Olinger GN; Boerboom LE
Thorac Cardiovasc Surg; 1993 Oct; 41(5):274-9. PubMed ID: 8303694
[TBL] [Abstract][Full Text] [Related]
18. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
Yang SS; Hearse DJ
Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036
[TBL] [Abstract][Full Text] [Related]
19. Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion.
Takahashi A; Chambers DJ; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1988 Nov; 96(5):730-40. PubMed ID: 3184967
[TBL] [Abstract][Full Text] [Related]
20. Cardioplegic protection of hearts with pre-arrest ischaemic injury: effect of glucose, aspartate, and lactobionate.
Choong YS; Gavin JB; Cottier DS
Thorac Cardiovasc Surg; 1995 Dec; 43(6):331-7. PubMed ID: 8775858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
